Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Inclusion of Additional Unintended Consequences in Economic Evaluation: A Systematic Review of Immunization and Tuberculosis Cost-Effectiveness Analyses.
Nymark, LS; Miller, A; VASSALL, A;
2021
PharmacoEconomics - open, (2021).5 4 10.1007/s41669-021-00269-4.
Evaluation of a Novel Culture System for Rapid Pathogen Identification and Detection of Cephalosporin Resistance in Neonatal Gram-negative Sepsis at a Tertiary Referral Unit in Harare, Zimbabwe.
Chimhini, G; OLARU, ID; Fitzgerald, F; Chisenga, M; Ferreyra, C; Malou, N; Piton, J; Chimhuya, S; YEUNG, S; De, S; Mujuru, HA; KRANZER, K;
2021
The Pediatric infectious disease journal, (2021).40 9 10.1097/INF.0000000000003155.
A STRUCTURED EXPERT ELICITATION TO INFORM AND VALIDATE MORTALITY EXTRAPOLATIONS FOR A COST-EFFECTIVENESS ANALYSIS OF DAPAGLIFLOZIN.
Willigers, B; Ouwens, M; BRIGGS, A; Darlington, O; Bhatt, P; Wittbrodt, E; Sinsakul, M; Heerspink, HL; Pollock, C; Filho, RF S P; Tangri, N; Kovesdy, C; Wheeler, D; Sanchez, JJ G;
2021
NEPHROLOGY DIALYSIS TRANSPLANTATION, (2021).36,
Global economic productivity losses from vision impairment and blindness.
MARQUES, AP; RAMKE, J; CAIRNS, J; Butt, T; Zhang, JH; Muirhead, D; Jones, I; Tong, BA M A; Swenor, BK; Faal, H; Bourne, RR A; Frick, KD; BURTON, MJ;
2021
EClinicalMedicine, (2021).35, 10.1016/j.eclinm.2021.100852.
Adaptive health technology assessment to facilitate priority setting in low- and middle-income countries.
NEMZOFF, C; RUIZ, F; Chalkidou, K; Mehndiratta, A; GUINNESS, L; Cluzeau, F; Shah, H;
2021
BMJ GLOBAL HEALTH, (2021).6 4 10.1136/bmjgh-2020-004549.
Optimal health and economic impact of non-pharmaceutical intervention measures prior and post vaccination in England: a mathematical modelling study.
Tildesley, MJ; VASSALL, A; Riley, S; JIT, M; SANDMANN, F; Hill, EM; Thompson, RN; Atkins, BD; EDMUNDS, J; Dyson, L; Keeling, MJ;
2021
medRxiv preprint (2021). 10.1101/2021.04.22.21255949.
Call for a pan-European COVID-19 response must be comprehensive - Authors' reply.
Priesemann, V; Brinkmann, MM; Ciesek, S; Cuschieri, S; Czypionka, T; Giordano, G; HANSON, C; Hens, N; Iftekhar, E; Klimek, P; Kretzschmar, M; Peichl, A; Perc, M; Sannino, F; Schernhammer, E; Schmidt, A; Staines, A; Szczurek, E;
2021
Lancet (London, England), (2021).397 10284 10.1016/s0140-6736(21)00462-1.
Mortality, neurodevelopmental impairments, and economic outcomes after invasive group B streptococcal disease in early infancy in Denmark and the Netherlands: a national matched cohort study.
Horváth-Puhó, E; Van Kassel, MN; Gonçalves, BP; De Gier, B; PROCTER, SR; PAUL, P; Van der Ende, A; Søgaard, KK; Hahné, SJ M; CHANDNA, J; Schrag, SJ; Van de Beek, D; JIT, M; Sørensen, HT; Bijlsma, MW; LAWN, JE;
2021
The Lancet. Child & adolescent health, (2021).5 6 10.1016/S2352-4642(21)00022-5.
An analysis of food demand in a fragile and insecure country: Somalia as a case study.
Hussein, M; LAW, C; Fraser, I;
2021
Food Policy, (2021).101, 10.1016/j.foodpol.2021.102092.
The thorny issue of value alignment: how development-focused health technology assessment can help find win-win situations for patients and healthcare systems and commercial investors.
Bouttell, J; BRIGGS, A; Hawkins, N;
2021
International journal of technology assessment in health care, (2021).37 1 10.1017/s026646232100026x.